A trial of treatment for pulmonary tuberculosis patients showing multiple resistance to anti-tuberculosis drugs. 1. a fundamental experiment of MIC of demethyl-chlortetracycline (LM) to M. tuberculosis and other mycobacteria
Takenaka, T.; Tsukamura, M.
Kekkaku 45(3): 93-96
1970
ISSN/ISBN: 0022-9776
PMID: 4987506
Accession: 042134196
PDF emailed within 1 workday: $29.90
Related References
Anastassov, V.I. 1982: Primary resistance to anti tuberculosis drugs in newly diagnosed cases of pulmonary tuberculosis and results of treatment Bulletin of the International Union Against Tuberculosis 57(1): 74Orikiriza, P.; Tibenderana, B.; Siedner, M.J.; Mueller, Y.; Byarugaba, F.; Moore, C.C.; Evans, E.E.; Bonnet, M.; Page, A.-L.; Bazira, J.; Boum, Y. 2015: Low resistance to first and second line anti-tuberculosis drugs among treatment naive pulmonary tuberculosis patients in southwestern Uganda Plos one 10(2): E0118191
Padmapriydarsini, C.; Mamulwar, M.; Mohan, A.; Shanmugam, P.; Gomathy, N.S.; Mane, A.; Singh, U.B.; Pavankumar, N.; Kadam, A.; Kumar, H.; Suresh, C.; Reddy, D.; Devi, P.; Ramesh, P.M.; Sekar, L.; Jawahar, S.; Shandil, R.K.; Singh, M.; Menon, J.; Guleria, R. 2022: Randomized Trial of Metformin with Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults with Pulmonary Tuberculosis Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 75(3): 425-434
Jugheli, L.; Rigouts, L.; Shamputa, I.C.; Bram de Rijk, W.; Portaels, F. 2008: High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 12(5): 561-566
Sgaragli, G.; Frosini, M. 2016: Human Tuberculosis II. M. tuberculosis Mechanisms of Genetic and Phenotypic Resistance to Anti-Tuberculosis Drugs Current Medicinal Chemistry 23(12): 1186-1216
Ghane Shirazi, R.; Kadivar, M.R.; Shafieian, R.; Hassani, K.H. 2000: Prevelence of Mycobacterium tuberculosis resistance to anti-TB drugs in patients with pulmonary tuberculosis in Fars province, 1999 American Journal of Tropical Medicine and Hygiene 62(3 Suppl): 355
Eufrásio, R.; Alcobia, M.; Correia, L. 2017: Pulmonary tuberculosis: Resistance pattern to first line anti-tuberculosis drugs in the Coimbra District, 2000-2011 Revista portuguesa de pneumologia 23(5): 300-302
Benitez Rodriguez, C.; Guzman, M.T.resa Viguri 1961: Demethyl-chlortetracycline in active pulmonary tuberculosis Prensa Med Mexicana 26(2): 120-123
Sonntag, H.G.; Ratschko, K.W. 1970: Studies of mycobacteria growth rates on cultures with 1 anti tuberculosis drug and those with several combined anti tuberculosis drugs Beitraege zur Klinik und Erforschung der Tuberkulose und der Lungenkrankheiten 141(4): 319-327
Puri, M.M.; Arora, V.K. 2003: Role of gallium arsenide laser irradiation at 890 nm as an adjunctive to anti-tuberculosis drugs in the treatment of pulmonary tuberculosis Indian Journal of Chest Diseases and Allied Sciences 45(1): 19-23
Al-Marri, M.R. 2001: Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 5(12): 1116-1121
Fedotova, Z.N.; Shesterina, M.V. 1978: Treatment of bronchial lesions in patients with pulmonary tuberculosis with primary resistance of mycobacteria to drugs Problemy Tuberkuleza 8: 31-34
El Hamdouni, M.; Ahid, S.; Bourkadi, J.E.; Benamor, J.; Hassar, M.; Cherrah, Y. 2020: Incidence of adverse reactions caused by first-line anti-tuberculosis drugs and treatment outcome of pulmonary tuberculosis patients in Morocco Infection 48(1): 43-50
Khudushina, T.A.; Voloshina, E.P.; Adamovich, N.V.; Maslakova, M.G.; Terekhova, N.D. 2005: Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis Problemy Tuberkuleza i Boleznei Legkikh 12: 37-39
Hu, Y.; Zheng, X.; Ning, Z.; Li, Q.; Zhang, Z.; Hoffner, S. 2016: Impact of genotypic and phenotypic resistance to second-line anti-tuberculosis drugs on treatment outcomes in multidrug-resistant tuberculosis in China International Journal of Mycobacteriology 5(Suppl 1): S34-S35
Grosset, J.; Zunic, L.; Morcrette, C. 2002: Épidémiologie mondiale de la tuberculose et de la résistance aux antibiotiques antituberculeux : La tuberculose - World epidemiology of tuberculosis and resistance against anti-tuberculosis drugs : Tuberculosis Annales de Medecine Interne (Paris) 153(2): 107-112
Mishin, V.I.; Komissarova, O.G.; Chukanov, V.I.; Kononets, A.S. 2009: The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs Problemy Tuberkuleza i Boleznei Legkikh 2: 50-52
Rastogi, N.; David, H.L. 1993: Mode of action of antituberculous drugs and mechanisms of drug resistance in Mycobacterium tuberculosis : Emergence of multiple-drug-resistant tuberculosis : fundamental and applied research aspects, global issues and current strategies Res. Microbiol. (Paris) 144(2): 133-143
Kang, W.-l.; Xie, Y.-g.; Tan, W.-g.; Chu, N.-h.; Li, L.; You, Y.-h.; Yang, Y.-z.; Wang, X.-m.; Yan, X.-l.; Miao, Z.-p.; Duanmu, H.-j. 2009: Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis Zhonghua Liu Xing Bing Xue Za Zhi 30(2): 179-183
Chino, H.; Hagiwara, E.; Sekine, A.; Kitamura, H.; Baba, T.; Shinohara, T.; Komatsu, S.; Ogura, T. 2016: [compliance Rate of Standard Treatment Regimen and Optimal Dose of Anti-Tuberculosis Drugs in Late Elderly Patients with Pulmonary Tuberculosis Kekkaku: 91(5): 495-502